AstraZeneca shares climb after earnings beat estimates as cancer drug portfolio drives strong growth

How 1 sources are covering this

• MintLean R·2h ago

  AstraZeneca shares climb after earnings beat estimates as cancer drug portfolio drives strong growth

  Adjusted earnings per share, excluding certain items, climbed 21% to $2.63 in the latest quarter, comfortably surpassing analysts' expectations

  Read at Mint →